The final report provides information to your clinician on whether a specific strain of Borrelia, Babesia and Bartonella is present in your cells or serum, and a quantification parameter (its Ct value, or Threshold Cycle).
Our PrediSpot test has been developed to provide your patients with the information they need to make better-informed decisions about their health and wellbeing.
Our team of molecular biologists use the latest medical techniques to analyse DNA extracted from your patient’s swab sample to identify variants or mutations, which can be used to predict if they are at an increased risk of developing certain diseases.
The tests we have created can accurately predict a patients’ risk of developing Alzheimer’s disease, asthma, Charcot-Marie-Tooth, coronary artery disease, Crohn’s disease, heart attack, heart disease, hypertension, multiple sclerosis, osteoporosis, rheumatoid arthritis, Sjögren’s syndrome, sudden cardiac death, systemic lupus erythematosus, thrombosis, type 1 diabetes and type 2 diabetes.
Our PrediSpot test is appropriate for healthy adults aged 18 or over who want to learn more about their health and do not have a history of these conditions in themselves or in members of their family. If your patient is feeling unwell or experiencing any symptoms that are causing concern, further evaluation or diagnostic testing may be more appropriate.
We will send you a sample collection kit in the mail. The box will include step-by-step instructions on the sample requirements (blood sample or swab) and details on how to return the sample back to us. We aim to get all results back to you within seven to 12 working days from when we receive your sample. Visit Our tests page to find out more about each individual test or contact us directly if you have any questions.
Download a sample report of our PrediSpot test.
Our PrediSpot test costs £750.